Pfizer plans to submit an sBLA by the end of this year, subject to discussions with U.S. FDA
The company will strengthen its position in the ‘green solvent’ market by increasing its capacity by 20% to 120,000 MTPA from 100,000 MTPA before the end of current fiscal
The company has reported total income of Rs. 129.96 crores during the period ended June 30, 2022.
Sandu Kumarvin is an Ayurvedic digestive and immunity booster for children and also offers several other benefits.
First and only PARP inhibitor to improve invasive disease-free survival, the primary endpoint, and overall survival, a key secondary endpoint, in these patients
Ministry of Ayush signed a MoU with Ministry of Micro, Small & Medium Enterprises (MSME) for the promotion of Ayush enterprises.
The total financial outlay of the scheme is Rs.500 crore for a period of five years from 2021-22 to 2025-26.
Torrent Pharmaceuticals has reported total income of Rs. 2377 crores during the period ended June 30, 2022.
Biopharma and CROs to benefit from simplified access to global research sites
India exported about Rs 33,321 crore and imported Rs 35,249 crore worth APIs and Bulk drugs in 2021-22.
Subscribe To Our Newsletter & Stay Updated
